Roche provides update on Phase III Skyscraper-01 study in PD-L1-high metastatic non-small cell lung cancer
SKYSCRAPER-01 is ongoing and the study remains blinded to patients and investigators
SKYSCRAPER-01 is ongoing and the study remains blinded to patients and investigators
LEO Pharma is developing delgocitinib cream for the treatment of moderate to severe chronic hand eczema, a hard-to-treat disease where there is a high unmet medical need for treatment
Global Initiative on Digital Health launched at the G2O Health Minister’s Meeting
Combating the prevalent stigma against TB in the society, India has been committed to providing, enabling and patient-centric support to all, individuals suffering from TB
Glenmark's current portfolio consists of 184 products authorized for distribution in the U.S. marketplace
Ryan has nearly 20 years of global legal and IP expertise in the pharmaceutical industry
Continuous learning is not just an option but a responsibility that every healthcare professional must shoulder
The instrument is fully integrated with Lonza’s latest WinKQCLSoftware to enable data integrity compliance, streamline training, and reduce validation burden
Jemperli is the only immuno-oncology treatment approved in the frontline setting for this patient population in combination with chemotherapy
Marks the World Head & Neck Cancer Day at the OCTF Conference
Subscribe To Our Newsletter & Stay Updated